Robbins Andrew R bought COGT
December 17, 2025 · Form 4 insider transaction
Robbins Andrew R bought 245,000 shares of Cogent Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
245,000
Price
$0.00
Total value
N/A
InsiderRobbins Andrew R
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after245,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates.